119 related articles for article (PubMed ID: 36540088)
1. Testosterone and quality of life in patients with dilated cardiomyopathy.
Diaconu R; Neagoe O; Mirea O; Tieranu E; Mustafa R; Balseanu TA; Donoiu I
Discoveries (Craiova); 2022; 10(3):e156. PubMed ID: 36540088
[TBL] [Abstract][Full Text] [Related]
2. Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.
Capota R; Militaru S; Ionescu AA; Rosca M; Baicus C; Popescu BA; Jurcut R
Health Qual Life Outcomes; 2020 Oct; 18(1):351. PubMed ID: 33126893
[TBL] [Abstract][Full Text] [Related]
3. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.
Huff CM; Turer AT; Wang A
Qual Life Res; 2013 Apr; 22(3):647-52. PubMed ID: 22544415
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure.
Nave-Leal E; Pais-Ribeiro J; Oliveira MM; Da Silva N; Soares R; Fragata J; Ferreira R
Rev Port Cardiol; 2010 Mar; 29(3):353-72. PubMed ID: 20635562
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between the Kansas City Cardiomyopathy Questionnaire and New York Heart Association in Assessing Functional Capacity and Clinical Outcomes.
Hawwa N; Vest AR; Kumar R; Lahoud R; Young JB; Wu Y; Gorodeski EZ; Cho L
J Card Fail; 2017 Apr; 23(4):280-285. PubMed ID: 27940335
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12.
Dos Reis MC; Nascimento JA; de Andrade GN; Costa ACS; Takada JY; Mansur AP; Bocchi EA; Dos Santos GMS; Spertus JA; Nakagawa NK
J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103041
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.
Watanabe-Fujinuma E; Origasa H; Bamber L; Roessig L; Toyoda T; Haga Y; Gwaltney C; Pieske B
Health Qual Life Outcomes; 2020 Jul; 18(1):236. PubMed ID: 32680513
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Nassif M; Fine JT; Dolan C; Reaney M; Addepalli P; Allen VD; Sehnert AJ; Gosch K; Spertus JA
JACC Heart Fail; 2022 Aug; 10(8):531-539. PubMed ID: 35902155
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.
Ravera A; Santema BT; Sama IE; Meyer S; Lombardi CM; Carubelli V; Ferreira JP; Lang CC; Dickstein K; Anker SD; Samani NJ; Zannad F; van Veldhuisen DJ; Teerlink JR; Metra M; Voors AA
Eur J Heart Fail; 2021 Apr; 23(4):567-577. PubMed ID: 33728762
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock's clinical score in predicting heart failure outcomes.
Sawadogo K; Ambroise J; Vercauteren S; Castadot M; Vanhalewyn M; Col J; Robert A
Qual Life Res; 2016 May; 25(5):1245-55. PubMed ID: 26456163
[TBL] [Abstract][Full Text] [Related]
11. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
[TBL] [Abstract][Full Text] [Related]
12. Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
Greene SJ; Butler J; Spertus JA; Hellkamp AS; Vaduganathan M; DeVore AD; Albert NM; Duffy CI; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
JAMA Cardiol; 2021 May; 6(5):522-531. PubMed ID: 33760037
[TBL] [Abstract][Full Text] [Related]
13. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of life quality in patients with chronic heart failure].
Fan ZJ; Lu YH; Sun LX; Yan JH; Li Q; Wang YJ; Zhuang X; Zhang ZF; Gu DF; Yang YJ
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3244-8. PubMed ID: 20193360
[TBL] [Abstract][Full Text] [Related]
15. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.
Arnold SV; Li Z; Vemulapalli S; Baron SJ; Mack MJ; Kosinski AS; Reynolds MR; Hermiller JB; Rumsfeld JS; Cohen DJ
JAMA Cardiol; 2018 Dec; 3(12):1151-1159. PubMed ID: 30476950
[TBL] [Abstract][Full Text] [Related]
16. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Spertus JA; Fine JT; Elliott P; Ho CY; Olivotto I; Saberi S; Li W; Dolan C; Reaney M; Sehnert AJ; Jacoby D
Lancet; 2021 Jun; 397(10293):2467-2475. PubMed ID: 34004177
[TBL] [Abstract][Full Text] [Related]
17. Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.
Gallagher AM; Lucas R; Cowie MR
ESC Heart Fail; 2019 Feb; 6(1):3-9. PubMed ID: 30311454
[TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries.
Johansson I; Joseph P; Balasubramanian K; McMurray JJV; Lund LH; Ezekowitz JA; Kamath D; Alhabib K; Bayes-Genis A; Budaj A; Dans ALL; Dzudie A; Probstfield JL; Fox KAA; Karaye KM; Makubi A; Fukakusa B; Teo K; Temizhan A; Wittlinger T; Maggioni AP; Lanas F; Lopez-Jaramillo P; Silva-Cardoso J; Sliwa K; Dokainish H; Grinvalds A; McCready T; Yusuf S;
Circulation; 2021 Jun; 143(22):2129-2142. PubMed ID: 33906372
[TBL] [Abstract][Full Text] [Related]
19. Neuroticism personality trait is associated with Quality of Life in patients with Chronic Heart Failure.
Samartzis L; Dimopoulos S; Manetos C; Agapitou V; Tasoulis A; Tseliou E; Pozios I; Kaldara E; Terrovitis J; Nanas S
World J Cardiol; 2014 Oct; 6(10):1113-21. PubMed ID: 25349656
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.
Hejjaji V; Tang Y; Coles T; Jones PG; Reeve BB; Mentz RJ; Spatz ES; Dunlay SM; Caldwell B; Saha A; Tarver ME; Tran A; Patel KK; Henke D; Piña IL; Spertus JA
Circ Heart Fail; 2021 Sep; 14(9):e008284. PubMed ID: 34465123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
